期刊文献+

Cox比例风险模型在原发性肝癌患者凝血功能分析中的应用 被引量:9

Application of Cox proportional hazard model in coagulation function analysis in patients with primary liver cancer
下载PDF
导出
摘要 目的应用Cox比例风险模型探讨原发性肝癌的临床分期和患者生存期与凝血功能的相关性,为临床治疗和预后提供可靠的评价指标。方法对228例原发性肝癌患者、52例普通肝病患者和52例健康对照者进行了血浆凝血功能检测,并观察肝癌分期与凝血功能的关系;进行随访并收集相关的预后资料。采用Cox比例风险模型分析凝血指标和原发性肝癌晚期患者生存期及血栓性疾病的关系。结果原发性肝癌患者凝血指标变化不仅与健康对照组的差异显著,而且随着肝癌分期程度的加重,凝血功能障碍加剧(P<0.05);D-聚体(D-dimer)、纤维蛋白原降解产物(FDP)、纤维蛋白原(FIB)和血小板(PLT)水平与晚期肝癌患者的远期生存呈负相关。结论凝血功能指标的检测能从多方面及时、准确地反映肝癌患者肝脏的损害程度及危险程度,动态地观察凝血功能指标有利于对肝癌患者的病情进行更好的监测和治疗。 Objective To explore the association of clinical staging and survival with coagulation parameters in patients with primary liver cancer by using Cox proportional hazard model so as to provide a parameter for clinical management and prognosis.Methods Coagulation parameters were evaluated in 228 patients with primary liver cancer,52 patients with common liver diseases and 52 healthy controls.The relationship between primary liver cancer staging and coagulation parameters was analyzed;follow-up examinations were performed.The Cox proportional hazard model was used to analyze the relationship between coagulation parameters and survival.Results The changes of coagulation parameters in the patients with primary liver cancer were significantly different from those in the normal controls.The effect of the disease on coagulation function became more obvious as the severity of liver cancer increased(P<0.05).The levels of D-dimer,fibrinogen degradation products(FDP),fibrinogen(FIB) and platelets(PLT) were negatively correlated with the long-term survival of patients with advanced liver cancer.Conclusion Coagulation parameters can timely and accurately reflect the lesion and risk extent in liver cancer patients.Dynamic monitoring of coagulation parameters may help ensure better surveillance and treatment for liver cancer patients.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期99-103,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省科技攻关项目(No.2009K01-78)~~
关键词 COX比例风险模型 凝血功能 原发性肝癌 肝癌分期 Cox proportional hazard model coagulation function primary liver cancer liver cancer staging
  • 相关文献

参考文献1

  • 1Massimo Franchini,Martina Montagnana,Giovanni Targher,Franco Manzato,Giuseppe Lippi. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer[J] 2007,Journal of Thrombosis and Thrombolysis(1):29~38

同被引文献103

  • 1许德翔,张飞.不同阶段乙型肝炎病毒感染患者凝血功能指标表达水平分析[J].临床军医杂志,2020(11):1349-1350. 被引量:5
  • 2周帅,张剑权,刘琪.原发性肝癌患者中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值的变化及临床意义[J].湖南师范大学学报(医学版),2020(4):34-37. 被引量:16
  • 3王克强,史继学.酶学检测作为肝癌标记物的研究进展[J].临床检验杂志,1994,12(2):100-102. 被引量:8
  • 4Kudo M. Review of 4th Single Topic Conference on HCC. Hepatocellular carcinoma: International consensus and controversies[J]. Hepatol Res, 2007,37 (Suppl 2) : 83-87.
  • 5Park JO, Lee SI, Song SY, et al. Measuring response insolid tumors:comparison of RECIST and WHO response criteria[J] Jpn J Clin Oncol,2003,33(10) :533-537.
  • 6Huang YH, Chen CH, Chang TT, et al. The role of transeatheter arterial embolization for patients with unreseetable hepatoeellular carcinoma: a nationwide, muhieentre study evaluated by cancer stage. Aliment Pharma- col Ther,2005,21 : 687 -694.
  • 7Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoem- bolisation versus symptomatic treatment in patients with unreseetable hep- atoeellular carcinoma: a randomised controlled trial. Lancet, 2002,359 : 1734-1739.
  • 8郑树国,李建伟,李剑斌,冯晓彬,王曙光,别平.腹腔镜肝切除术的初步经验[J].中华消化外科杂志,2007,6(6):424-427. 被引量:10
  • 9Bakhshi H, Alavi-Moghaddam M, Wu KC, et al. D-dimer as an applicable test for detection of posttraumatic deep vein thrombosis in lower limb fracture[J].Am J Orthop (Belle Mead NJ),2012,41(6) :78 -80.
  • 10Tamura Y, Mori S, Asada S, et al. Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplasty[J]. Thromb J, 2014,12 : 11.

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部